Royal Bank Of Canada Genetron Holdings LTD Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.87 - $1.04 $13 - $16	-16 Reduced 42.11%	22 $0
Q1 2023 May 15, 2023	SELL	$0.91 - $1.23 $1 - $2	-2 Reduced 5.0%	38 $0
Q4 2022 Feb 14, 2023	BUY	$0.8 - $1.12 $14 - $20	18 Added 81.82%	40 $0
Q4 2021 Feb 14, 2022	SELL	$5.81 - $14.39 $871 - $2,158	-150 Reduced 87.21%	22 $0
Q3 2021 Nov 15, 2021	BUY	$11.55 - $20.3 $1,536 - $2,699	133 Added 341.03%	172 $2,000
Q2 2021 Aug 16, 2021	BUY	$17.9 - $23.29 $698 - $908	39 New	39 $1,000

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.